"The stock had dropped 6.5% on Monday, even after the company warning of a revenue shortfall due to a lowered outlook for COVID product sales, and as Chairman Noubar Afeyan disclosed more share sales. "
Read More
"Moderna co-founder Noubar Afeyan said he expects more will be known about omicron in the next seven to 10 days."
Read More
"With governments around the world debating whether to authorize Covid-19 vaccine booster doses, Moderna Inc. co-founder Noubar Afeyan envisions a time when the shot could become routine."
Read More
"The new strains stem from "a natural process but it is concerning," Noubar Afeyan said in an interview on Bloomberg Television. "
Read More